North and South Pavilion works completed
We are excited to share that the redevelopment works of the North Pavilion and South Pavilion of the Human Technopole campus have been completed.
The buildings, originally built for Expo Milano 2015 to accommodate exhibition space and restaurants will now host laboratory and office space as well as state-of-the-art facilities for life science research.
The North Pavilion works were completed in mid-March 2021. The ground floor of the pavilion will host HT’s Cryo-EM Facility and Light Microscopy Facility equipped with latest technologies. The first floor of the building will host an open space office setting with worksations for microscopy image analysis. The building has been adapted to meet the technical requirements of the microscopes, for example by managing the environmental conditions of the rooms and inserting special platforms to avoid vibrations and support the machines’ weight.
The South Pavilion works were completed in mid-April 2021. The full redevelopment of the building meets the engineering and testing needs of the laboratories and is in line with energy efficiency requirements. It will host lab spaces for Neurogenomics and Genomics and research activities as well as part of HT’s core facilities. It will have feature 60 and 90 workstations (depending on the final layout) and will link to Palazzo Italia, Human Technopole’s institutional headquarters, through a suspended tunnel.
Both buildings will now be furnished and set up to welcome Human Technopole researchers in the coming months.
Share:
You could also like:
-
Two ERC-funded projects to search for tumours’ weaknesses
Human Technopole has once again been awarded by Europe’s prestigious public body for funding of scientific research conducted within the European Union, the European Research Council (ERC), for two projects on the origin of tumours, their evolution and the development of resistance to therapies. The two studies could contribute to the identification of new anti-cancer targeted […]
-
COVID-19: How SARS‑CoV‑2 Enters Human Cells
A study by the University of Padua and Human Technopole, together with the University of Milan and the European Institute of Oncology, published in Cell Reports Medicine, reveals that SARS-CoV-2, the virus that causes COVID-19, binds the RAGE receptor present on the surface of specific human immune cells to penetrate them and pathologically alter their function. This study also shows how the involvement of RAGE, previously known only in the context of other pathophysiological conditions, such as obesity and diabetes, is implicated in the degree of severity with which COVID-19 can manifest.
-
Italy joins the iCARE4CVD consortium
The Human Technopole and Mario Negri institute for Pharmacological Research are among 33 leading international partners who have joined forces to better understand cardiovascular diseases and optimise future prevention and treatment.
-
Study tour “Austrian Life Science Innovation Ecosystem” in Vienna
The Human Technopole Centre for Innovation and Technology Transfer (CITT) continues its international promotion activities by learning about foreign innovation ecosystems. From 28 to 30 November 2023, CITT is organising a study tour to meet the leading players in basic and applied research within the Austrian ecosystem, with the support of the Italian Embassy in Vienna and the Italian Trade Agency.
-
Annotating human genes: where do we stand now?
In a perspective article published in Nature, Piero Carninci and colleagues discuss the status of human gene annotation and how high-throughput RNA sequencing technologies have accelerated the discovery of non-coding RNA genes with unknown functions and will promote the completion of the human gene catalogue.